Conference of the Indian Stroke Association highlights stroke incidence, gaps in rehabilitation, and future advancements in ...

Apr. 3, 2025 — A global study establishes long-term risk of stroke. Findings shows one in five people who experience a minor stroke or TIA will have another stroke within 10 ... 17 Modifiable ...

Abstract: Spasticity is a common motor symptom that disrupt muscle contraction and hence ... The effectiveness of the NEUSPA model is validated using classic experiments from the literature and data ...

A new study has discovered what researchers say is the first drug to fully reproduce the effects of physical stroke rehabilitation in model mice, following from human studies. A new study by UCLA ...

“Ultimately, we hope that people feel like there’s a hopeful message in here — that there are actually so many things that you can work on, and then not only your risk of stroke is ...

Having a stroke is a life-altering event. For those who survive, the road to recovery can be long, difficult, and filled with challenges. In Australia, where over 400,000 people live with the effects ...

术后，根据患者的具体情况精细调整了刺激参数，并启动了脊髓电刺激治疗。令人欣喜的是，患者左上肢痉挛症状得到了明显缓解，肌张力显著降低。这一治疗效果不仅减轻了患者的痛苦，也为后续的康复训练提供了有利条件。

Fascinating - as a stroke survivor, of course I need this, but realize that it was probably too long ago. However, I'm fascinated that this was the first time I read about the damage to the ...

Background: Spasticity and loss of function in an affected arm are common after stroke. Although botulinum toxin is used to reduce spasticity, its functional benefits are less easily demonstrated.

Background OnabotulinumtoxinA has demonstrated significant benefit in adult focal spasticity. This study reviews the injection patterns (i.e., muscle distribution, dosing) of onabotulinumtoxinA ...

Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.